Daniel N. Swisher, Jr

2017 - Sunesis Pharmaceuticals

In 2017, Daniel N. Swisher, Jr earned a total compensation of $565.5K as Former CEO and President at Sunesis Pharmaceuticals, a 63% decrease compared to previous year.

Compensation breakdown

Option Awards$33,465
Salary$528,519
Other$3,466
Total$565,450

Swisher received $528.5K in salary, accounting for 93% of the total pay in 2017.

Swisher also received $33.5K in option awards and $3.5K in other compensation.

Rankings

In 2017, Daniel N. Swisher, Jr's compensation ranked 11,418th out of 14,666 executives tracked by ExecPay. In other words, Swisher earned more than 22.1% of executives.

ClassificationRankingPercentile
All
11,418
out of 14,666
22nd
Division
Manufacturing
4,472
out of 5,768
23rd
Major group
Chemicals And Allied Products
1,627
out of 2,074
22nd
Industry group
Drugs
1,343
out of 1,730
22nd
Industry
Pharmaceutical Preparations
1,048
out of 1,329
21st
Source: SEC filing on April 25, 2018.

Swisher's colleagues

We found two more compensation records of executives who worked with Daniel N. Swisher, Jr at Sunesis Pharmaceuticals in 2017.

2017

William Quinn

Sunesis Pharmaceuticals

Chief Financial Officer

2017

Eric Bjerkholt

Sunesis Pharmaceuticals

Chief Financial Officer

News

You may also like